The association between anticholinergic burden and mobility: a systematic review and meta-analyses

Abstract Background As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of the challenges with polypharmacy is the associated increase in anticholinergic exposure to older adults. In addition, several studies suggest a...

Full description

Bibliographic Details
Main Authors: Geofrey O. Phutietsile, Nikoletta Fotaki, Hamish A. Jamieson, Prasad S. Nishtala
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Geriatrics
Subjects:
Online Access:https://doi.org/10.1186/s12877-023-03820-6
_version_ 1827979402361700352
author Geofrey O. Phutietsile
Nikoletta Fotaki
Hamish A. Jamieson
Prasad S. Nishtala
author_facet Geofrey O. Phutietsile
Nikoletta Fotaki
Hamish A. Jamieson
Prasad S. Nishtala
author_sort Geofrey O. Phutietsile
collection DOAJ
description Abstract Background As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of the challenges with polypharmacy is the associated increase in anticholinergic exposure to older adults. In addition, several studies suggest an association between anticholinergic burden and declining physical function in older adults. Objective/Purpose This systematic review aimed to synthesise data from published studies regarding the association between anticholinergic burden and mobility. The studies were critically appraised for the strength of their evidence. Methods A systematic literature search was conducted across five electronic databases, EMBASE, CINAHL, PSYCHINFO, Cochrane CENTRAL and MEDLINE, from inception to December 2021, to identify studies on the association of anticholinergic burden with mobility. The search was performed following a strategy that converted concepts in the PECO elements into search terms, focusing on terms most likely to be found in the title and abstracts of the studies. For observational studies, the risk of bias was assessed using the Newcastle Ottawa Scale, and the Cochrane risk of bias tool was used for randomised trials. The GRADE criteria was used to rate confidence in evidence and conclusions. For the meta-analyses, we explored the heterogeneity using the Q test and I2 test and the publication bias using the funnel plot and Egger’s regression test. The meta-analyses were performed using Jeffreys’s Amazing Statistics Program (JASP). Results Sixteen studies satisfied the inclusion criteria from an initial 496 studies. Fifteen studies identified a significant negative association of anticholinergic burden with mobility measures. One study did not find an association between anticholinergic intervention and mobility measures. Five studies included in the meta-analyses showed that anticholinergic burden significantly decreased walking speed (0.079 m/s ± 0.035 MD ± SE,95% CI: 0.010 to 0.149, p = 0.026), whilst a meta-analysis of four studies showed that anticholinergic burden significantly decreased physical function as measured by three variations of the Instrumental Activities of Daily Living (IADL) instrument 0.27 ± 0.12 (SMD ± SE,95% CI: 0.03 to 0.52), p = 0.027. The results of both meta-analyses had an I2 statistic of 99% for study heterogeneity. Egger’s test did not reveal publication bias. Conclusion There is consensus in published literature suggesting a clear association between anticholinergic burden and mobility. Consideration of cognitive anticholinergic effects may be important in interpreting results regarding the association of anticholinergic burden and mobility as anticholinergic drugs may affect mobility through cognitive effects.
first_indexed 2024-04-09T21:36:13Z
format Article
id doaj.art-d01f6514f10643d9ba0728cb521a1e39
institution Directory Open Access Journal
issn 1471-2318
language English
last_indexed 2024-04-09T21:36:13Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Geriatrics
spelling doaj.art-d01f6514f10643d9ba0728cb521a1e392023-03-26T11:17:27ZengBMCBMC Geriatrics1471-23182023-03-0123111410.1186/s12877-023-03820-6The association between anticholinergic burden and mobility: a systematic review and meta-analysesGeofrey O. Phutietsile0Nikoletta Fotaki1Hamish A. Jamieson2Prasad S. Nishtala3Department of Pharmacy and Pharmacology, University of BathDepartment of Pharmacy and Pharmacology, University of BathDepartment of Medicine, University of OtagoDepartment of Pharmacy and Pharmacology, University of BathAbstract Background As people age, they accumulate several health conditions, requiring the use of multiple medications (polypharmacy) to treat them. One of the challenges with polypharmacy is the associated increase in anticholinergic exposure to older adults. In addition, several studies suggest an association between anticholinergic burden and declining physical function in older adults. Objective/Purpose This systematic review aimed to synthesise data from published studies regarding the association between anticholinergic burden and mobility. The studies were critically appraised for the strength of their evidence. Methods A systematic literature search was conducted across five electronic databases, EMBASE, CINAHL, PSYCHINFO, Cochrane CENTRAL and MEDLINE, from inception to December 2021, to identify studies on the association of anticholinergic burden with mobility. The search was performed following a strategy that converted concepts in the PECO elements into search terms, focusing on terms most likely to be found in the title and abstracts of the studies. For observational studies, the risk of bias was assessed using the Newcastle Ottawa Scale, and the Cochrane risk of bias tool was used for randomised trials. The GRADE criteria was used to rate confidence in evidence and conclusions. For the meta-analyses, we explored the heterogeneity using the Q test and I2 test and the publication bias using the funnel plot and Egger’s regression test. The meta-analyses were performed using Jeffreys’s Amazing Statistics Program (JASP). Results Sixteen studies satisfied the inclusion criteria from an initial 496 studies. Fifteen studies identified a significant negative association of anticholinergic burden with mobility measures. One study did not find an association between anticholinergic intervention and mobility measures. Five studies included in the meta-analyses showed that anticholinergic burden significantly decreased walking speed (0.079 m/s ± 0.035 MD ± SE,95% CI: 0.010 to 0.149, p = 0.026), whilst a meta-analysis of four studies showed that anticholinergic burden significantly decreased physical function as measured by three variations of the Instrumental Activities of Daily Living (IADL) instrument 0.27 ± 0.12 (SMD ± SE,95% CI: 0.03 to 0.52), p = 0.027. The results of both meta-analyses had an I2 statistic of 99% for study heterogeneity. Egger’s test did not reveal publication bias. Conclusion There is consensus in published literature suggesting a clear association between anticholinergic burden and mobility. Consideration of cognitive anticholinergic effects may be important in interpreting results regarding the association of anticholinergic burden and mobility as anticholinergic drugs may affect mobility through cognitive effects.https://doi.org/10.1186/s12877-023-03820-6Anticholinergic burdenAntimuscarinicPhysical functionGaitPolypharmacyElderly
spellingShingle Geofrey O. Phutietsile
Nikoletta Fotaki
Hamish A. Jamieson
Prasad S. Nishtala
The association between anticholinergic burden and mobility: a systematic review and meta-analyses
BMC Geriatrics
Anticholinergic burden
Antimuscarinic
Physical function
Gait
Polypharmacy
Elderly
title The association between anticholinergic burden and mobility: a systematic review and meta-analyses
title_full The association between anticholinergic burden and mobility: a systematic review and meta-analyses
title_fullStr The association between anticholinergic burden and mobility: a systematic review and meta-analyses
title_full_unstemmed The association between anticholinergic burden and mobility: a systematic review and meta-analyses
title_short The association between anticholinergic burden and mobility: a systematic review and meta-analyses
title_sort association between anticholinergic burden and mobility a systematic review and meta analyses
topic Anticholinergic burden
Antimuscarinic
Physical function
Gait
Polypharmacy
Elderly
url https://doi.org/10.1186/s12877-023-03820-6
work_keys_str_mv AT geofreyophutietsile theassociationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT nikolettafotaki theassociationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT hamishajamieson theassociationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT prasadsnishtala theassociationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT geofreyophutietsile associationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT nikolettafotaki associationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT hamishajamieson associationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses
AT prasadsnishtala associationbetweenanticholinergicburdenandmobilityasystematicreviewandmetaanalyses